Börk Balkan

Oral and Injectable (Non-insulin) Pharmacological Agents for Type 2 Diabetes

Figure 12, Time course of change from baseline in HbA1c and fasting plasma glucose (FPG) concentrations in bromocriptine and placebo-treated subjects (311).

Figure 16, Efficacy of dapagliflozin plus metformin compared to glipizide plus metformin.

Figure 10, [Pharmacologic effects of GLP-1.GLP-1 Receptor Agonists (Incretin Mimetics)].

Figure 3, [Relationship between baseline HbA1c and...].

Figure 2, Sites of action of the current and potential future pharmacological therapies for the treatment of type 2 diabetes.

Figure 13, Structure of human amylin and Pramlintide®.

Figure 11, Comparison of exenatide vs basal insulin on 24-hour glucose pattern (245).

Figure 5, [Effect of metformin on fasting...].

Figure 8, Processing of pro-glucagon-like peptide-1